Molnupiravir Capsule Manufacturer in India
Molnupiravir Capsule Manufacturer in India – The novel coronavirus disease, also known as COVID-19, emerged in late December 2019 in China and has rapidly spread all across the globe. The last year went with heated discussions about ending the COVID-19 pandemic. All focused on the effectiveness, availability, and safety of vaccines. However, all the discussions got shut when the Molnupiravir Capsule rolled out in the market. We, Saphnix Lifesciences – Dedicated to the Discovery, Development, and therapeutic options, are the Top Molnupiravir Capsule Manufacturer in India. Molnupiravir Capsule is a pill your physician or doctor could prescribe for that you could pick up from a pharmacy. The final analysis of the trial showed 89% efficacy in cutting the risk of hospitalization and death-risk in the patients with high risk. Experts say it is a pill meant to be taken after experiencing COVID-19 symptoms. When an individual consumes the drug (Molnupiravir), it enters the bloodstream and inhibits the ability of the SARS-CoV-2 virus to replicate. We’ve dedicated our professional career to making this life-saving drug accessible to the masses being the Top Molnupiravir Capsule Manufacturer in India.
Folks willing to know more about this drug, manufacturing services, capabilities, or anything else can call us at +91-8146661517 or write an email at saphnixlifesci@gmail.com.
Mandatory Requirements for Administration | Molnupiravir Capsule
Molnupiravir Capsules are an effective treatment for COVID-19, approved by FDA in India. Molnupiravir in these capsules is a nucleoside analogue, functions by blocking SARS-CoV-2 replication by viral mutagenesis. The physician or medic can prescribe Molnupiravir Capsule for treating mild-to-moderate coronavirus disease in adults (18+). Molnupiravir is prescribed when the result of the viral test is POSITIVE. Molnupiravir Capsule is for patients with high risk and progression to severe COVID-19, including death or hospitalization. Also, Molnupiravir Capsules are an effective medicine for whom other treatment options of coronavirus disease 2019 are not clinically appropriate or accessible.
Requirements for Administration:-
- Not for use in patients with age less than 18 years.
- Approved for short-term use; not longer than five (5) consecutive days.
- Molnupiravir is not ideal for the patients requiring hospitalization due to COVID-19.
- Neither approved for pre-exposure nor post-exposure prophylaxis for prevention of
COVID-19
Molnupiravir Capsules can only be prescribed for an individual by licensed or authorized physicians, physician assistants, and advanced practice registered nurses. The physician must prescribe this anti-infective drug for the duration authorized by the upper authorities.
Facts About Molnupiravir Capsule | You Must Know About
Before initiating the therapy with Molnupiravir, one should consider its known possible adverse reactions and benefits. The dosage of Molnupiravir Capsule depends on the directions of the physician. In general, 800 mg (four 200 mg capsules) should be taken orally every 12 hours for five (5) days, and one can take these capsules with or without food (Not accurate information, consult with the doctor for full details). Since the safety and efficacy of Molnupiravir Capsule haven’t been established, an individual patient should not use it for more than 5 (five) consecutive days.
More Highlights of Molnupiravir Capsule:-
- Molnupiravir drug (COVID-19 treatment) is available in solid preparations (Capsules 200mg).
- Start taking Molnupiravir Capsule immediately after the diagnosis of COVID19 and within five days of symptom onset.
- An individual patient should complete a 5-day treatment course is while continuing isolation following public health recommendations to minimize transmission of SARS-CoV-2 and maximize viral clearance.
- During pregnancy, physicians don’t prescribe Molnupiravir Capsules due to embryo-fetal toxicity.
- Molnupiravir Capsule may affect the bone and cartilage growth, thus, not advised for use in minor patients (less than 18 years of age).
Further, due to limited studies on the use of Molnupiravir Capsule, no contraindications and drug interactions have been identified. However, one should consult with the physician for more detailed information on this subject.
Adverse Effects of Molnupiravir Capsules | Possible Side Effects
Molnupiravir functions by targeting RdRP, which is an essential enzyme for COVID-19 replication. It seems to play a vital role in the pathophysiology of COVID-19. It is effective in treating coronavirus disease 2019 (animal studies shows). However, randomized clinical trials are necessary to ensure its therapeutic effects in the future among patients with COVID-19. Also, the side effects are not recognized clearly. The most common adverse reactions (reported) of Molnupiravir Capsules include:-
- Diarrhea,
- Nausea,
- and Dizziness.
The long-term side-effects of Molnupiravir Capsules are unknown. Therefore, one should take it as per the dose and directions directed by the physician. For more information on the adverse reactions of Molnupiravir drugs, confer with experts.
Molnupiravir Capsule Manufacturer in India | Saphnix Lifesciences
Saphnix Life Sciences is a leading manufacturer, marketer, and distributor of pharmaceuticals, including life-saving drugs like Molnupiravir Capsule. With passion and determination, we are endeavor to fight against COVID-19. We strive to simplify care for patients with life-threatening diseases all across India.
Being the Best Molnupiravir Capsule Manufacturer in India, are putting constant efforts to make this drug accessible through our market persistence, strong capabilities, and patient-centric approach. To know more about Saphnix Lifesciences, contact now. Pick out the most convenient method to connect with us from the below-listed.
Contact Details!
Name: Saphnix Lifesciences
Address: Village Barotiwala, Utrathya Paonta Sahib – 173025, Sirmaur, Himachal Pradesh, India
Phone: +91 8146661517
Email: saphnixlifesci@gmail.com.
